Biocon raises ₹1,070 crore from Kotak Special Situations Fund
Bioconwill use the proceeds to finance Biocon Biologics' acquisition of the biosimilars business of Viatris.
- Biocon Biologics completed the acquisition of Viatris’ global biosimilars business in November 2022.
- With this investment, the $1 billion Kotak Special Situations Fund is fully committed.
AdvertisementKotak Special Situations Fund (KSSF) said on Wednesday it has invested ₹1,070 crore in biopharmaceutical major Biocon.
Biocon will use the proceeds to finance its subsidiary Biocon Biologics' acquisition of the biosimilars business of Viatris. Biocon Biologics completed the acquisition of Viatris’ global biosimilars business in November 2022.
“This investment in Biocon comes at a pivotal point when Biocon is forward-integrating its biosimilars business. Going forward, Biocon will realise full revenues and profits from this business. With this, the $1 billion Kotak Special Situations Fund is fully committed. India continues to offer unique and attractive risk-adjusted opportunities for hybrid funding strategies,” said Srini Sriniwasan, managing director, Kotak Investment Advisors that manages KSSF.
Biocon said, in its latest earnings concall, that it entered into definitive agreements with KSSF for structured funding. This, the company added, would help reduce its net debt.
“Viatris continues to provide commercial and other transaction services to Biocon Biologics as part of a pre-agreed Transition Services Agreement. In parallel, Biocon Biologics is designing a bespoke country-specific strategy and business model that optimises for revenues and profitability. This, we believe, will create value for all our stakeholders,” said
Mazumdar-Shaw had also shared that they had also drawn up a comprehensive integration plan, and intended to start migrating business operations in a phased manner.
“We are delighted to partner with Biocon and this acquisition financing supports Biocon’s journey of becoming a world leading, fully integrated biosimilars enterprise,” said Eshwar Karra, CEO – KSSF at Kotak Investment Advisors.
Popular on BI
- Billionaire investor Mark Mobius says he's been able to get his money out of China, but investing in the country is still a 'dilemma' amid national security laws
- The Carnival cruise passenger who went overboard and remains missing was on his first cruise and it became his 'happy place,' his fiancée said
- The new Barbie movie used so much pink paint on set that it caused an international shortage, according to its production designer
- Attractiveness of gold depends on US Fed's moves, say analysts
- Coal India’s ₹4,000 crore offer for sale subscribed 4x times
- Nvidia's Jensen Huang started with a $10 million failure before shifting gears to become a $1 trillion company
- Meet the top Nifty50 performers in FY23
- Apple to declare the 12-inch MacBook as obsolete on June 30